Health Trials

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)

3

Review clinical trials related to Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Linezolid Plus Standard of Care

The aim of the study is to assess whether targeting virulence factors by administering linezolid in addition to standard antibiotic treatment improves outcomes in patients with Staphylococcus aureus bacteraemia.

Participants needed: 606
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, Basel, SwitzerlandUpdated: Jul 13, 2026Locations: 12
Eligibility criteria

Staphylococcus aureus (S. aureus) grown from at least one blood culture [+3]

Administration of the initial drug treatment not feasible within 72 hours since... [+12]

Read more
Status: Recruiting

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

The goal of this study is to investigate if benzylpenicillin is a better treatment option than cloxacillin in patients with penicillin-susceptible Staphylococcus aureus bacteraemia.

Participants needed: 420
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Region SkaneUpdated: Apr 30, 2026Locations: 1
Eligibility criteria

allergy to penicillin, [+6]

Read more
Status: Recruiting

Linezolid Plus Standard of Care

The aim of the study is to assess whether targeting virulence factors by administering linezolid in addition to standard antibiotic treatment improves outcomes in patients with Staphylococcus aureus bacteraemia.

Participants needed: 606
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, Basel, SwitzerlandUpdated: Mar 24, 2026Locations: 12
Eligibility criteria

Staphylococcus aureus (S. aureus) grown from at least one blood culture [+3]

Administration of the initial drug treatment not feasible within 72 hours since... [+12]

Read more